Advertisement Boston Scientific acquires CryoCor - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Boston Scientific acquires CryoCor

Boston Scientific, a provider of medical devices, has acquired California-based medical technology company CryoCor. The transaction follows the definitive agreement announced on April 16, 2008.

Under the terms of the transaction, all remaining outstanding CryoCor shares are entitled to receive $1.35 per share in cash, for a total of approximately $17.6 million. CryoCor is now an indirect, wholly-owned subsidiary of Boston Scientific.